Health

Venture capital funding for Indian firms hit a six-year high of $12.1bn in the first six months of 2021

The newly formed RxCapital has made its first investment, in metabolic and cardiovascular disease drug developer Rivus Pharmaceuticals' $35m series A round.

Craig Cimini will be the remaining managing director at health insurer Cigna's corporate venture capital subsidiary.

SAP.io took part in email software provider Sedna's $34m series B round while Byju's picked up BCC-backed learning app developer Toppr in a deal reportedly sized at about $150m.

Genomics analytics platform developer Sophia Genetics has gone public ten years after it was co-founded by researchers from EMBL, Stanford and University of Geneva

Dog DNA test developer Embark Veterinary raised the capital in a round led by SoftBank Vision Fund 2 at a $700m post-money valuation.

Co-founder and CEO Kelli Luginbuhl talks to GUV about how the Duke spinout re-imagines the manufacturing of complex biologics.

The heath and nutrition product manufacturer's Otsuka Nutraceutical Emerging Ventures vehicle will target early-stage investments in North America.

AGC, JSR Life Sciences and Merck & Co all scored exits as the synthetic biology technology developer floated on Nasdaq, whose valuation reportedly stands at nearly $2bn.

Takeda has returned to back the cancer therapeutics developer’s series D round after committing $120m in equity and milestone financing just over 18 months ago.

Our data suggest that valuations in the HR tech space are picking up. Two deals stories from last week confirm the trend.